​

10x Genomics Ownership | Who Owns 10x Genomics?

OverviewForecastRevenueFinancialsChartTranscripts

10x Genomics Ownership Summary

10x Genomics is owned by 86.42% institutional investors, 2.17% insiders, and 11.42% retail investors. Fmr is the largest institutional shareholder, holding 10.90% of TXG shares. ARK Innovation ETF is the top mutual fund, with 6.80% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

TypeName% Inst% Insiders% Retail
Stock10x Genomics86.42%2.17%11.42%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryHealthcare Information Services Stocks 52.99%9.95%37.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr13.01M10.90%$253.05M
Vanguard group10.19M8.53%$198.18M
Ark investment management9.31M7.80%$181.15M
Blackrock6.39M5.35%$124.34M
Nikko asset management americas6.15M5.15%$119.34M
Sumitomo mitsui trust6.14M5.15%$119.48M
Morgan stanley5.77M4.84%$112.30M
Price t rowe associates inc /md/2.87M2.41%$55.90M
Baillie gifford2.74M2.30%$53.33M
Brown capital management2.48M2.08%$48.31M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Venrock management vi2.11M100.00%$40.98M
Sands capital ventures481.77K3.14%$9.37M
Ark investment management9.31M1.61%$181.15M
Nikko asset management americas6.15M1.38%$119.34M
Soleus capital management719.00K1.23%$13.98M
Brown capital management2.48M0.98%$48.31M
Birchview capital, lp30.00K0.54%$583.50K
Pdt partners261.88K0.48%$5.09M
Granite investment partners461.01K0.37%$8.97M
Slow capital105.53K0.33%$2.05M

Top Buyers

HolderShares% AssetsChange
Ark investment management9.31M1.61%3.03M
Nikko asset management americas6.15M1.38%2.53M
Sumitomo mitsui trust6.14M0.09%2.52M
Ubs asset management americas1.93M0.01%1.79M
Vanguard group10.19M0.00%1.09M

Top Sellers

HolderShares% AssetsChange
Baillie gifford2.74M0.04%-4.68M
Generation investment management llp---2.88M
Rtw investments, lp502.86K0.15%-1.05M
Sands capital management2.33M0.13%-1.05M
Price t rowe associates inc /md/2.87M0.01%-783.27K

New Positions

HolderShares% AssetsChangeValue
Norges bank991.05K0.00%991.05K$19.28M
Soleus capital management719.00K1.23%719.00K$13.98M
Deerfield management company, l.p. (series c)597.00K0.19%597.00K$11.61M
Mirae asset global etfs141.71K0.01%141.71K$2.76M
Hsbc91.33K0.00%91.33K$1.80M

Sold Out

HolderChange
Mather group, llc.-4.00
Northwest investment counselors-6.00
Princeton global asset management-9.00
Rakuten securities-10.00
Lifesteps financial-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242671.14%104,336,340-0.97%861.12%1578.28%71-7.79%
Jun 30, 2024262-10.58%105,357,3692.80%881.20%145-14.71%75-
Mar 31, 20242935.40%102,484,0186.88%851.31%1709.68%75-9.64%
Dec 31, 20232785.70%95,888,6195.44%801.36%15537.17%83-17.00%
Sep 30, 2023263-5.05%90,941,8862.12%771.33%113-22.07%10026.58%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Innovation ETF8.23M6.80%-
ARK Disruptive Innovation Full Composite7.43M6.17%893.39K
Nikko AM ARK Disruptive Innovation A USD3.64M3.01%-68.06K
Vanguard Total Stock Mkt Idx Inv3.24M2.67%-8.69K
ARK Genomic Revolution ETF2.85M2.35%13.71K
Vanguard Small Cap Index2.53M2.09%4.95K
ARK Genomic Revolution2.52M2.09%393.34K
Nikko AM ARK Pstv Chg Innovt P JPY Acc2.42M2.00%-41.69K
Fidelity Select Medical Tech and Devcs2.20M1.82%198.94K
Fidelity Growth Company Fund2.14M1.77%-467.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 22, 2024Saxonov Serge Chief Executive OfficerSell$91.61K
Nov 22, 2024Hindson Benjamin J. See RemarksSell$79.49K
Aug 22, 2024Saxonov Serge Chief Executive OfficerSell$152.05K
Aug 22, 2024Hindson Benjamin J. See RemarksSell$98.03K
Aug 22, 2024McAnear Justin J. Former Chief Financial OfficerSell$66.71K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2-3
2024 Q1-9
2023 Q4-11
2023 Q3-14

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 86.42%, followed by 2.17% insiders and 11.41% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 52.99%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Fmr (13.01M shares, 10.90%), Vanguard group (10.19M shares, 8.53%), and Ark investment management (9.31M shares, 7.80%). Together, they hold 27.23% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Innovation ETF is the top mutual fund holder of 10x Genomics shares, with 6.80% of its total shares outstanding invested in 8.23M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools